Latest News
  • Cancer risks: Are we getting them right?

    Researching cancer mortality over the past few months has proved to be a bit of an eye-opener, and in three ways: firstly the level of excess mortality seen in a number of cancers, secondly the duration over which an extra risk persists, and thirdly that excess mortality may extend over a considerable period.   Some of the high excess death rates (EDRs) were noted stage II/III disease, where mortality was
    Read more ›

  • Turning the world on its head

    Turning the world of insurance on its head, that is. We are just back from the Society of Actuaries’ annual ‘Underwriting Issues and Innovations’ seminar in Chicago, where we go to learn what is happening in what one might call paradoxical North American markets where underwriting sophistication and tradition have very different meanings compared to most other places.   In North America, and in the US especially, underwriting to the nth
    Read more ›

  • Underwriting and calculators

    On our travels we speak to a lot of people about underwriting manual developments. One topic which comes up time and again is calculators: great invention or the work of The Devil?   Some underwriting manuals have had simple calculators for many years, for example for pulmonary function tests, financial ratios and BMI, all of which are designed to help the underwriter by speeding up and simplifying assessment. In recent
    Read more ›

  • Is it time to ditch rating tables?

    By Dr Kevin Somerville   Ah, rating tables – convenient, elegant and simple. They’ve been used for decades and even a trainee underwriter can use them. So much easier to understand than those calculators and so much easier to compare the offerings in the various underwriting manuals and complain that ratings are too high or low… Besides there’s the current mantra in the market: simplicity. Tables have the virtue of
    Read more ›

  • Jigglypuff or out of puff?

    Do you know a Jigglypuff from a Squirtle? If not then you may have missed one of the biggest things of 2016. Pokémon GO was one of the most popular apps of 2016 with over 500 million downloads.   It is a free, location-based, augmented reality game developed by Niantic in collaboration with Nintendo through the Pokémon company. Players use the GPS capability of their mobile device to find, capture
    Read more ›

  • Wearable devices: product development and continuous underwriting

    We have written about wearable devices several times now and have concentrated mainly on the user’s perspective. Now we write about how insurers are incorporating wearables and the data they collect into products.   One such insurer is MLC in Australia which launched its ‘Life Insurance on Track’ product in November 2015. The key component of the programme is a Garmin Vivosmart HR fitness tracker which needs to be paired
    Read more ›

  • Wearable technology – two different perspectives

    We have written before about wearables from a number of different angles, including Gary’s perspective as an owner in August 2015. Time for an update.   It’s now almost eighteen months since I bought the Fitbit HR. Let’s start with some of my numbers: Steps taken: ranged from a daily low of 5,500 to a highest of 35,000 in a day (which included a gym visit and a full-on day
    Read more ›

  • How do you sleep?

    In our articles on wearables and insurance products we highlight that some insurers, in addition to the step count measured by a wearable device, also use sleep duration as one of their criteria for policyholders to gain premium discounts.   Sleep plays a vital role in mental and physical well-being, quality of life and safety. Sleep helps the brain to function correctly and during sleep the brain prepares for the
    Read more ›

  • The real digital health?

    So far in our articles we have been pretty positive about all aspects of e-health, digital health, e-medicine, wearable devices, etc, and what these will bring. And of course Gary is a pretty enthusiastic Fitbit wearer. But there are a few potential ‘trip hazards’ with underwriting significance.   Are wearables really going to be a rich source – or even a reasonably useful source – of data for risk evaluation
    Read more ›

  • Serum cholesterol: mounting evidence against?

    The British Medical Journal (BMJ) has just published a study the findings of which suggest that replacing saturated fats with vegetable oils rich in linoleic acid does not reduce the risk of coronary heart disease (CHD)1.   Using data from the Minnesota Coronary Experiment (MCE) which was a double-blind randomised trial conducted in the late 1960s/early 1970s, researchers found that linoleic-rich vegetable oil effectively reduced cholesterol levels but without any
    Read more ›